About Us

GlioQuell is a biopharmaceutical company dedicated to developing technologies and therapeutics targeting cellular bioenergetics. Based on cutting-edge proprietary science, the company is discovering and developing novel therapeutics for treating refractory brain tumours and other diseases with significant medical and societal burden. Our innovative strategy is designed for targeted modulation of cellular metabolism to affect the viability of specific cell types, including highly proliferative malignant glioma cells. Our founding directors and advisors include leaders in mitochondrial biology and clinical medicine, with decades of experience in discovery and translation of novel findings into the clinic.

 

Our Work

Cure for Brain Tumours
Click Here
Ageing research
Click Here
Cellular Bioenergetics
Click Here
Innovative Science
Click Here
Previous slide
Next slide

News

GlioQuell Limited, 152-160 City Road, London, EC1V 2NX

Get In touch

Leave us a message and we will get back to you shortly

020 45771 1821

info@glioquell.com

GlioQuell Limited, 152-160 City Road, London, EC1V 2NX